Inhibrx Biosciences INBX
NASDAQ INBX
$100.32 -4.51 (-4.30%)
As of: Sep 30, 2026 · 3:59 PM EDT

Inhibrx Biosciences (INBX) Asset Utilization Ratio (2024 - 2026)

Updated

Inhibrx Biosciences' (INBX) Asset Utilization Ratio stood at 0.01 in Q2 2026, up 31.1% from 0.01 a year earlier.

Analysis

Inhibrx Biosciences (INBX) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Starting with Q3 2024, Inhibrx Biosciences' Asset Utilization Ratio history includes 6 quarters.

  • Across earlier years, Asset Utilization Ratio came in at 0.00 in FY2024.
  • The Q2 2026 figure is the highest quarterly Asset Utilization Ratio since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.49
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.47
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.52
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.44
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.53
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.40
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.58
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 0.47
10 Inhibrx Biosciences 1.54 Bn 1.54 Bn - 0.01
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.01
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Dec 31, 2024 0.01
Sep 30, 2024 0.01
API Access

Inhibrx Biosciences Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=INBX&period=max&api_key=YOUR_API_KEY